Cas:3107-98-0 dimethyl octafluoroadipate manufacturer & supplier

Chemical Name:dimethyl octafluoroadipate

CAS.NO:3107-98-0

Synonyms:MFCD00042267;Octafluoroadipic Acid Dimethyl Ester;Dimethyl Octafluorohexanedioate;Perfluoroadipic Acid Dimethyl Ester;Dimethyl Perfluoroadipate;Dimethyl Octafluoroadipate;PC3015T;Octafluor-adipinsaeure-dimethylester;Dimethyl-octafluor-hexandioat;octafluoro-hexanedioic acid dimethyl ester;Octafluorohexanedioic Acid Dimethyl Ester

Molecular Formula:C₈H₆F₈O₄

Molecular Weight:318.11800

HS Code:2917190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:120 °C

Density:1,5 g/cm3

Index of Refraction:1.3475

PSA:52.60000

Exact Mass:318.01400

LogP:1.87360

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD00042267 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Octafluorohexanedioic Acid Dimethyl Ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Octafluoroadipic Acid Dimethyl Ester Use and application,Octafluoroadipic Acid Dimethyl Ester technical grade,usp/ep/jp grade.

Related News: The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819. dimethyl octafluoroadipate manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. dimethyl octafluoroadipate supplier Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days. dimethyl octafluoroadipate vendor ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. dimethyl octafluoroadipate factory The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market.